Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate
- PMID: 12867431
- DOI: 10.1074/jbc.M302267200
Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate
Abstract
The conservation of positively charged residues in the N terminus of the hepatitis C virus (HCV) envelope glycoprotein E2 suggests an interaction of the viral envelope with cell surface glycosaminoglycans. Using recombinant envelope glycoprotein E2 and virus-like particles as ligands for cellular binding, we demonstrate that cell surface heparan sulfate proteoglycans (HSPG) play an important role in mediating HCV envelope-target cell interaction. Heparin and liver-derived highly sulfated heparan sulfate but not other soluble glycosaminoglycans inhibited cellular binding and entry of virus-like particles in a dose-dependent manner. Degradation of cell surface heparan sulfate by pretreatment with heparinases resulted in a marked reduction of viral envelope protein binding. Surface plasmon resonance analysis demonstrated a high affinity interaction (KD 5.2 x 10-9 m) of E2 with heparin, a structural homologue of highly sulfated heparan sulfate. Deletion of E2 hypervariable region-1 reduced E2-heparin interaction suggesting that positively charged residues in the N-terminal E2 region play an important role in mediating E2-HSPG binding. In conclusion, our results demonstrate for the first time that cellular binding of HCV envelope requires E2-HSPG interaction. Docking of E2 to cellular HSPG may be the initial step in the interaction between HCV and the cell surface resulting in receptor-mediated entry and initiation of infection.
Similar articles
-
Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction.J Virol. 2006 Nov;80(21):10579-90. doi: 10.1128/JVI.00941-06. Epub 2006 Aug 23. J Virol. 2006. PMID: 16928753 Free PMC article.
-
Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry.J Virol. 2005 Sep;79(18):11588-97. doi: 10.1128/JVI.79.18.11588-11597.2005. J Virol. 2005. PMID: 16140736 Free PMC article.
-
A potential role of the heparan sulfate in the hepatitis C virus attachment.Acta Virol. 2008;52(1):7-15. Acta Virol. 2008. PMID: 18459830
-
Specific interaction of the envelope glycoproteins E1 and E2 with liver heparan sulfate involved in the tissue tropismatic infection by hepatitis C virus.Glycoconj J. 2012 May;29(4):211-20. doi: 10.1007/s10719-012-9388-z. Epub 2012 Jun 3. Glycoconj J. 2012. PMID: 22660965
-
Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus.Adv Exp Med Biol. 1992;313:341-53. doi: 10.1007/978-1-4899-2444-5_33. Adv Exp Med Biol. 1992. PMID: 1332443 Review.
Cited by
-
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies.Vaccines (Basel). 2021 Mar 20;9(3):291. doi: 10.3390/vaccines9030291. Vaccines (Basel). 2021. PMID: 33804732 Free PMC article. Review.
-
Members of 3-O-Sulfotransferases (3-OST) Family: A Valuable Tool from Zebrafish to Humans for Understanding Herpes Simplex Virus Entry.Open Virol J. 2013;7:5-11. doi: 10.2174/1874357901307010005. Epub 2013 Jan 21. Open Virol J. 2013. PMID: 23358893 Free PMC article.
-
Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy.Biosci Rep. 2021 Jul 30;41(7):BSR20210290. doi: 10.1042/BSR20210290. Biosci Rep. 2021. PMID: 34132790 Free PMC article. Review.
-
Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review.Lipids Health Dis. 2010 Jan 28;9:8. doi: 10.1186/1476-511X-9-8. Lipids Health Dis. 2010. PMID: 20109174 Free PMC article. Review.
-
The Importance of Heparan Sulfate in Herpesvirus Infection.Virol Sin. 2008 Dec 1;23(6):383-393. doi: 10.1007/s12250-008-2992-1. Virol Sin. 2008. PMID: 19956628 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources